comparemela.com

Latest Breaking News On - Sanofi regeneron - Page 8 : comparemela.com

Telemedicine expands reach of asthma practices

SAN ANTONIO — Providers can use telemedicine to engage patients with asthma who face obstacles in access to care remotely, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“You can use a telemedicine encounter as a way to increase your presence at your hospital or to help a rural hospital,” Allison C. Ramsey, MD, FACAAI,

Alirocumab improves coronary plaque burden in asymptomatic patients with FH

PCSK9 inhibition with alirocumab, on top of high-intensity statin therapy, resulted in significant coronary plaque regression among patients with familial hypercholesterolemia and no clinical atherosclerotic CVD, researchers reported.The results of the phase 4, open-label, multicenter, single-arm ARCHITECT study were published in Circulation.

Telemedicine saves time, money in penicillin allergy de-labeling

SAN ANTONIO — Providers can use telemedicine to conduct penicillin and other drug allergy screenings, saving time and costs, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“Telemedicine is a way for us to spread our tentacles a little bit and improve our reach,” Allison C. Ramsey, MD, FACAAI, FAAAAI, clinical assistant

Benefits outweigh risks when switching biologics for rheumatoid arthritis

Patients with rheumatoid arthritis who achieve only a partial response with adalimumab demonstrate a low risk for worsened symptoms and a high likelihood of meaningful improvement when switching to sarilumab, according to data.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.